IE
MRKR icon

Israel Englander’s Marker Therapeutics MRKR Stock Holding History

Israel Englander’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,108
Closed -$50.1K – 6207
2024
Q4 		$50.1K Buy
+16,108
New +$57K ﹤0.01% 5593
2023
Q2 		– Sell
-30,778
Closed -$22K – 6485
2023
Q1 		$22K Buy
30,778
+13,846
+82% +$32.9K ﹤0.01% 5843
2022
Q4 		$45K Buy
+16,932
New +$58.4K ﹤0.01% 5806
2022
Q3 		– Sell
-9,214
Closed -$30K – 7343
2022
Q2 		$30K Sell
9,214
-14,034
-60% -$46.7K ﹤0.01% 6366
2022
Q1 		$102K Sell
23,248
-42,875
-65% -$245K ﹤0.01% 6133
2021
Q4 		$628K Sell
66,123
-5,969
-8% -$79.3K ﹤0.01% 4845
2021
Q3 		$1.22M Sell
72,092
-64,371
-47% -$1.32M ﹤0.01% 4467
2021
Q2 		$3.81M Buy
136,463
+114,303
+516% +$3.01M ﹤0.01% 3118
2021
Q1 		$496K Buy
22,160
+20,124
+988% +$460K ﹤0.01% 4835
2020
Q4 		$30K Buy
+2,036
New +$31.6K ﹤0.01% 5114
2019
Q4 		– Sell
-4,709
Closed -$240K – 4491
2019
Q3 		$240K Buy
+4,709
New +$278K ﹤0.01% 3688
2019
Q2 		– Sell
-17,758
Closed -$1.17M – 4324
2019
Q1 		$1.17M Buy
+17,758
New +$1.04M ﹤0.01% 2766
2018
Q4 		– Sell
-3,479
Closed -$315K – 4022
2018
Q3 		$315K Buy
+3,479
New +$299K ﹤0.01% 3465
2017
Q2 		– Sell
-1,103
Closed -$50K – 3703
2017
Q1 		$50K Sell
1,103
-1,358
-55% -$60.4K ﹤0.01% 3388
2016
Q4 		$95K Buy
+2,461
New +$115K ﹤0.01% 3199

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AAM
AR Asset Management West Hollywood, California $546M AUM 24.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Israel Englander's MRKR Position: Q1 2025 in Review

Israel Englander sold out of Marker Therapeutics (MRKR) in Q1 2025, closing a stake of 16,108 shares — an estimated $50.1K sold.

Israel Englander first reported a position in MRKR in Q4 2016 and held it in 15 quarters. The position peaked at $3.81M in Q2 2021. 32 funds tracked by Wall St. Rank hold MRKR as of Q1 2025.

  • Israel Englander reported no remaining Marker Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Israel Englander sold 16,108 Marker Therapeutics shares in Q1 2025, an estimated $50.1K.
  • Israel Englander first reported a position in Marker Therapeutics in Q4 2016 and held it in 15 quarters.
  • Israel Englander's Marker Therapeutics position peaked at $3.81M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.